MedTrace Logo

Development and Validation of a Multi-target, Blood-based NAFLD Diagnosis Test

NCT05108415 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2023-03-23

No results posted yet for this study

Summary

Multi-omics approach was used to identify patterns of serological biomarkers to diagnose NAFLD. The purpose of this study is to develop and validate a blood-based assay to diagnose NAFLD by collecting blood sample from healthy patients undergoing routine screening ultrasonography and from patients recently diagnosed with NAFLD.

Conditions

  • NAFLD
  • NASH - Nonalcoholic Steatohepatitis

Sponsors & Collaborators

  • mProbe Inc.

    collaborator INDUSTRY

  • HBI Solutions Inc.

    lead INDUSTRY

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-31
Primary Completion
2023-12-31
Completion
2024-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05108415 on ClinicalTrials.gov